Sign in
Taking people in United StatesNo phase

Nasal airway device for sleep apnea in children with low muscle tone

Tests a self-supporting nasal airway device for sleep apnea in children with low muscle tone.

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the site
Trial code
Registry title
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
Status
Recruiting
People taking part
40 people, planned
Started
16 Nov 2022
Expected to end
Aug 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Self-Supporting Nasopharyngeal Airway (ssNPA)
Record updated
19 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people with low muscle tone in the upper airway who have obstructive sleep apnea. This is when the airway gets blocked during sleep. It tests a device placed in the nose to keep the airway open.

Age
3 Years to 21 Years
Sex
All
Disease stage
Newly diagnosed obstructive sleep apnea, confirmed by an overnight sleep study: AHI>10, or AHI>5 with oxygen level (SpO2) dropping to <=75%. At least one symptom is needed, such as snoring 3 or more nights per week, daytime sleepiness, or hyperactive or inattentive behaviour. Tonsil size must be 2+ or smaller.
Earlier treatment
Must have already had removal of the tonsils and adenoids, or have a medical reason not to have tonsil removal.

Main reasons for not taking part

  • Milder sleep study results than the trial asks for, or a medical reason the nose device cannot be used
  • Carbon dioxide levels >60 mmHg for >10% of sleep time on the sleep study
  • Narrowing or collapse lower in the airway, or moderate/severe softening of the windpipe (tracheobronchomalacia)
  • Bleeding disorder or need for blood-thinning medicine
  • Active COVID 19 infection, severe autism, or chest disorders that limit breathing

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Children with Hypotonic Upper Airway Obstruction (HUAO): This includes those who newly diagnosed with obstructive sleep apnea (OSA). These children will undergo overnight polysomnography to determine the presence of OSA (apnea-hypopnea index [AHI]>10 or AHI>5 with nocturnal hypoxemia defined as oxygen saturation by pulse oximetry [SpO2] nadir <=75%)
  • All subjects require the presence of at least one symptom of OSA (such as snoring 3 or more nights per week, daytime sleepiness, or hyperactive/inattentive behaviors)
  • Post adenotonsillectomy or those with contraindications to tonsillectomy
  • Tonsil size 2+ or smaller
  • Parent/caregivers willing and able to provide informed consent and child willing and able to provide assent, where appropriate

Who cannot take part

  • Any medical reason why Self-Supporting Nasopharyngeal Airway (ssNPA) therapy may not be suitable
  • Need for anticoagulative therapy
  • Active Coronavirus (COVID) 19 infections
  • Psychiatric, medical, or social factors likely to invalidate assessments, make adherence with ssNPA highly unlikely or make local follow-up at 8 weeks unfeasible. Some psychiatric conditions may be provoked or exacerbated by OSA, and those most commonly implicated - Attention Deficit/Hyperactivity Disorder, Conduct Disorder, and Oppositional Defiant Disorder - will not be exclusions. However, more pervasive conditions such as severe autism will be excluded
  • Bleeding disorder
  • Restrictive thoracic disorders
  • AHI ≤10 on polysomnogram (PSG) without hypoxemia or AHI<5 with hypoxemia
  • End-tidal carbon dioxide (ETCO2) or Transcutaneous carbon dioxide (TCO2) values >60 mmHg for >10% of sleep time on PSG
  • Presence of supraglottic airway collapse or more distal airway stenosis or collapse (for example glottic, subglottic stenosis, or concern for distal airway stenosis or malacia)
  • Moderate/severe tracheobronchomalacia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 21 years old?

Where in United States

  • The University of MichiganAnn Arbor, United StatesContact: Louise M O'Brien, PhDTaking people

About the trial

What the trial wants to find out

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

The 2 groups in the trial

  • Self-Supporting Nasopharyngeal Airway (ssNPA)Treatment being tested
  • Standard of CareNo study treatment, for comparison

    Waitlist control group: While waiting, participants will continue to receive the treatment they would have had before which will likely include being placed on the waiting list for positive airway pressure (PAP). After a period of being on the waitlist (8 weeks) there is an option to cross-over to the device arm.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
Plain-language title
Nasal airway device for sleep apnea in children with low muscle toneGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05527652, who can take part
Record updated
19 August 2026